A Clinical Study of Calderasib (MK-1084) With Rosuvastatin and Metformin in Healthy People (MK-1084-016)
Clinical trial NCT07222098 · COMPLETED
Trial details
- NCT number
- NCT07222098
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-19
- Primary completion
- 2025-12-14
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.